会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明专利
    • Mosaic serine protease, msp and its use
    • MOSAIC丝氨酸蛋白酶,MSP及其用途
    • JP2008247864A
    • 2008-10-16
    • JP2007094184
    • 2007-03-30
    • Univ Of Tokushima国立大学法人徳島大学
    • KIDO HIROSHIOKUMURA YUJI
    • A61K38/48A61K39/12A61K39/145A61P5/00A61P31/12A61P31/16A61P31/18A61P43/00C12N7/00C12N9/99C12N15/09C12Q1/37G01N33/15G01N33/50
    • Y02A50/60
    • PROBLEM TO BE SOLVED: To promote a safer and more effective antiviral agent, and basic and applied research on highly pathogenic avian influenza, HPAI, and to establish a method for diagnosing abnormal production of a peptide hormone related to MSP under a situation that no vaccine nor drug having specific effectiveness against HPAI are practically used and an existing drug causes a serious side effect.
      SOLUTION: MSPL, MSPS and TMPRSS13 inhibitors belonging to mosaic serine protease, MSP; a screening method for the above inhibitor using the degree of decomposition or cleavage of a substrate caused by these enzymes as an index; an antivirus agent and a therapeutic agent for peptide hormone disorder having the inhibitor as an active ingredient; an activation agent for enhancing infection and propagation of an HPAI virus and enabling its mass production; a therapeutic agent for peptide hormone disorder having the above enzymes as an active ingredient; an agent for diagnosing a hormone disorder using the amount of genetic expression of the above enzymes as an index; and the like.
      COPYRIGHT: (C)2009,JPO&INPIT
    • 要解决的问题:为了促进更安全,更有效的抗病毒剂,以及高致病性禽流感,HPAI的基础和应用研究,并建立了一种诊断与MSP有关的肽激素异常生成的方法 没有实际使用对HPAI具有特异效力的疫苗或药物,现有的药物会引起严重的副作用。 解决方案:MSPL,MSPS和TMPRSS13抑制剂属于马赛克丝氨酸蛋白酶,MSP; 使用由这些酶引起的底物的分解或裂解程度作为指标的上述抑制剂的筛选方法; 抗病毒剂和具有抑制剂作为活性成分的肽激素病症治疗剂; 用于增强HPAI病毒的感染和繁殖并使其大量生产的活化剂; 具有上述酶作为活性成分的肽激素病症治疗剂; 使用上述酶的遗传表达量作为指标诊断激素障碍的药剂; 等等。 版权所有(C)2009,JPO&INPIT